Clinical Trials Browser

Terminated × INDUSTRY × amrubicin × Clear all

NCT01904253 2024-09-05

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Phase 2 Terminated

Small Cell Lung Carcinoma

NCT00286169 2022-04-12

Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

Phase 3 Terminated

Small Cell Lung Carcinoma